Ramsey Alloush

Ramsey focuses his practice on corporate and securities law as it relates to all areas of biotechnology. He regularly acts as outside counsel to domestic and international biotechnology and pharmaceutical companies, bringing a unique set of skills, combining his experience from government, corporate and law firm practice which allows him to provide the full strategic representation for his clients. He advises innovative startup and incubators as well as small to mid cap companies on corporate formation; registered and private offerings; regulatory and compliance; ongoing reporting; and corporate and commercial matters. 

Additionally, Ramsey served as general counsel for a privately held pharmaceutical company. In his capacity, he was responsible for all segments of the organization including its securities filings, employment, intellectual property filings, compliance matters and debt and equity offerings through its acquisition by a publicly traded company. Ramsey also served as a legal fellow at the U.S. Securities & Exchange Commission, Division of Enforcement, where he was responsible for conducting litigation activities, including drafting pleadings, motions and briefs and conducting discovery. Prior to starting Alloush LLP, Ramsey worked for Medicis Pharmaceutical Corporation (NYSE: MRX).  

Business Handshake

Select Representative Matters:​​​​

  • Advising on the exclusive license, manufacturing, and supply of a series of pharmaceutical assets.

  • Advising a client on a complex dispute regarding a number of issues as a result of its recent acquisition of a product franchise. 

  • Advising on the purchase of a series of biopharmaceutical assets including NDAs, ANDAs, and 510Ks.

  • Advising on the creation and implementation of state and federal compliance programs as it relates to the Drug Supply Chain Supply Act.

  • Restructuring and implementing a corporate compliance program, sampling program and state licensing compliance program on behalf of a pharmaceutical client.

  • Acting as issuers counsel for a healthcare technology company and advising on its Regulation D and simultaneous Regulation S offering.

  • Acting as issuers counsel for a specialty pharmaceutical company and advising on its Regulation D offering.

  • Acting as investment bank counsel on a series of secondary offerings.

  • Advising a private equity firm on its divestment of convertible debt in a medical research and development company.

  • Advising a US corporation on its acquisition of several medical device and pharmaceutical assets in the US.

  • Advising a broker-dealer in its acquisition of a competing firm.

  • Advising a privately held pharmaceutical company on its sale of shares to a publicly traded pharmaceutical company.

  • Advising several medium to large US and foreign companies on a variety of antitrust, corporate formation and governance, healthcare/pharmaceutical regulatory and labor and employment matters.


  • Georgetown University Law Center, Masters of Law, LL.M. in Taxation

  • Georgetown University Law Center, Masters of Law, LL.M. in Securities and Financial Regulation

  • Shepard Broad Law Center at Nova Southeastern University, J.D., Corporate Law

Bar Admissions

  • District of Columbia

  • New York

  • Massachusetts